Prof. Peter Uchenna Nwangwu, a Nigerian-American professional living in the United States, has been named "Business Man of the Year 2005", by the Business Advisory Council of the United States, Washington, D.C. Prof. Nwangwu is one of twelve men in the United States selected for this distinguished honor. In March 2006, Nwangwu will receive the prestigious trophy in Washington, D.C at a presentation ceremony honoring him and the other recipients selected across the nation. Their names will be published in a full-page add in the Wall Street Journal announcing the recipients of the coveted award.
This award of "Business Man of the Year 2005" announced by the Business Advisory Council on December 15, 2005, is the third distinguished honor conferred on Prof. Nwangwu within 30 days in the United States. During the first week of December 2005, U.S. Congressman Tom Reynolds (R-NY), chairman of the National Republican Congressional Committee, announced that Prof. Nwangwu was the recipient of the eminent "2005 President Ronald Reagan Republican Gold Medal", awarded annually by the National Republican Congressional Committee, Washington, D.C. As recipient of the gold medal, Prof. Nwangwu's name will be permanently listed in the ranks of the Republican Honor Roll at the National Republican Congressional Committee headquarters in Washington, D.C.
In addition to the "2005 Ronald Reagan Republican Gold Medal" by the National Republican Congressional Committee, and the "Businessman of the Year 2005", by the Business Advisory Council, the Board of Editors of the American Biographical Institute announced on December 14, 2005 that Prof. Peter Nwangwu was selected "Man of the Year 2005" by the American Biographical Institute, Raleigh, North Carolina. Prof. Nwangwu who lives in Midland, Texas, home of President George Bush, is originally from Ogidi, Anambra State, Nigeria. Some of his current positions include president and chairman of Universal Pharmacy Consultants, Inc., president and chairman of South Atlantic Petroleum, Inc, and president and chairman of the Infinity Group, Inc, all in Midland, Texas. In the early to mid 80's he served as professor of pharmacology and Toxicology at St. John's University College of Pharmacy, New York. Before accepting the position at St. John's University, he served as the Director of Clinical Research at Florida A & M University, Tallahassee, Florida.
Professor Peter Nwangwu is a highly educated Nigerian-American, with two earned doctorate degrees from the University of Nebraska, who has lived in the United States for 34 years. In a recent book, "The Nigerian-Americans," by Professor Ogbaa, published in the United States by Greenwood Press, Prof Nwangwu, along with Hakeem Olajuwon and Philip Emeagwali, were among the top 12 Nigerians who were selected and documented to have made the most significant positive impact and contributions to the American society. Prof. Nwangwu has previously received several honors and awards in the United States and Europe, including biographical listings in over twenty prestigious reference books such as, Men of Achievement, 1981, Who's Who in Frontier Science and Technology, 1984/1985, World Book of Honor, The Marquis Who's Who in the World, 7th Edition, The International Who's Who of Contemporary Achievement, 1984, Personalities of America, 1981/82, Community Leaders of America, 12th Edition, 1981, 5,000 Personalities of the World, Edition one, Two Thousand Notable Americans, International Book of Honor, 1st World Edition, The Directory of Distinguished Americans, 1981, International Who's Who of Professionals, 2004 Edition.
Prof Nwangwu has made many remarkable achievements including the invention of two new techniques in pharmacology that are used widely worldwide, invention of seven new drugs that are patented in the United States, the authorship and publication of the book, "Concepts and Strategies in New Drug Development," Praeger Publishers, New York (1983), which is best seller in the field of new drug development in U.S, Canada and Europe. In addition to these, Prof Nwangwu is the first scientist in the world to document and publish the first in vivo murine ventricular tachycardia in a single surface electrocardiogram lead, which is now used widely as a model of human cardiomyopathy for medical research studies in cardiovascular disease worldwide. Scientists all over the world, including scientists at Harvard Medical School, quote Prof Nwangwu in their research publications in this area of medical research.
Prof Nwangwu is a medical scientist with both academic and research experience at U.S. universities in the field of pharmacy and pharmacology, has served as a practicing pharmacist in the U.S. at both hospital and community pharmacy practice, and is also a well respected industrial pharmacist and pharmaceutical company executive. He served as president and chairman of a pharmaceutical manufacturing company in the U.S for 15 years, and also served as a member of the Technical and Drug Regulatory Committee of the National Pharmaceutical Alliance, Washington, D.C. With a master's degree in Medicinal Chemistry and Pharmacognosy, and Pharmacodynamics and Toxicology, a doctor of pharmacy (Pharm.D.) degree in Clinical Pharmacy and Biopharmaceutics, and a doctor of philosophy (Ph.D.) degree in Medical Sciences with specialization in Cardiovascular Pharmacology, Prof Nwangwu is widely regarded by some of his professional colleagues as one of the top ten most educated pharmacists/pharmacologists in the world. He is a fellow of the American College of Clinical Pharmacology, and a fellow of the American Society of Consultant Pharmacists. He is a member of the prestigious United States Scientific and Technology think-tank group of experts, "The Council of Healthcare and Biotechnology Advisors", Gerson Lehrman Group, New York, New York; this is a select group of distinguished scientific and technical professionals carefully assembled by Gerson Lehrman Group to provide paid healthcare and biotechnology market research, industry recommendations, and consulting services worldwide. Furthermore, Prof. Nwangwu has served on the editorial board of several distinguished international scientific journals such as: Editorial/Advisory Board, Clinical Toxicology Consultant, Contributing Editor, Methods and Findings in Experimental and Clinical Pharmacology, Contributing Editor, Drugs of Today, and Contributing Editor, Drugs of the Future. In addition to his popular textbook on new drug development, he is author of over 40 scientific research and professional articles in refereed international journals. He serves as co-chairman of the Business Advisory Council of the National Republican Congressional Committee, Washington, D.C.